Home LiteratureArticle Details
PMID: 2957954 Published · ppublish English Journal Article

Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model.

Antimicrobial agents and chemotherapy ·Vol. 31 ·No. 8 ·1987-08-00 ·Pages 1243-50

Fernandes PB, Hardy D, Bailer R, McDonald E, Pintar J, Ramer N, Swanson R, Gade E

Abstract

There is poor correlation between the MICs and zone sizes obtained for erythromycin against Haemophilus influenzae. The effect of two media, Mueller-Hinton medium supplemented with 3% lysed horse blood and 10 micrograms of NAD per ml (MHA + LYHB) and Mueller-Hinton agar supplemented with 1% bovine hemoglobin and 1% IsoVitaleX (MHA + HGB), on the MICs and zone sizes of erythromycin against H. influenzae was determined. The effect of three different methods for inoculum preparation on the susceptibility of H. influenzae was also determined. The MICs were independent of the method of inoculum preparation, but the zone sizes were smaller if the inoculum was carefully adjusted to contain approximately 10(8) CFU/ml. MICs were higher and zone sizes were smaller when MHA + HGB was used instead of MHA + LYHB. Good correlation was found when MHA + LYHB was used for determining the MIC and MHA + HGB was used for determining susceptibility by the disk method. When the inoculum was adjusted to match a McFarland 0.5 standard, the viable counts had to be approximately 10(8) CFU/ml for good correlation between MICs and zone sizes. A-56268, a new macrolide antibiotic, was tested against H. influenzae, and its MICs and tentative breakpoints against this organism were determined. The MICs obtained by various methods were correlated with in vivo efficacy by using a mouse septicemia model. MICs obtained on MHA + HGB or MHA + LYHB incubated without a 5% CO2 atmosphere showed the best correlation with in vivo efficacy.

MeSH Terms
Animals Anti-Bacterial Agents/blood,pharmacology,therapeutic use Clarithromycin Culture Media Erythromycin/analogs & derivatives,blood,pharmacology,therapeutic use Female Haemophilus Infections/drug therapy Haemophilus influenzae/drug effects Kinetics Mice Mice, Inbred C3H Microbial Sensitivity Tests Sepsis/drug therapy,microbiology,prevention & control
Chemicals
Anti-Bacterial Agents Culture Media Erythromycin Clarithromycin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Fernandes P B
Hardy D
Bailer R
McDonald E
Pintar J
Ramer N
Swanson R
Gade E
References (15)
15 references, click to expand
  1. Effect of pH on the activity of erythromycin against 500 isolates of gram-negative bacilli.
    Appl Microbiol. 1970 Nov;20(5):754-6 PMID: 4991920
  2. Regression analysis, proposed interpretative zone size standards, and quality control guidelines for a new macrolide antimicrobial agent, A-56268 (TE-031).
    J Clin Microbiol. 1987 Jun;25(6):1079-82 PMID: 2954995
  3. Otitis media of infancy and early childhood. A double-blind study of four treatment regimens.
    Am J Dis Child. 1976 Sep;130(9):965-70 PMID: 8980
  4. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
    Scand J Infect Dis Suppl. 1983;39:106-8 PMID: 6606222
  5. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
    Antimicrob Agents Chemother. 1984 Apr;25(4):529-31 PMID: 6732223
  6. Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1).
    Mayo Clin Proc. 1985 Mar;60(3):189-203 PMID: 3974301
  7. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
    Diagn Microbiol Infect Dis. 1986 Jan;4(1):37-41 PMID: 3484692
  8. Susceptibility testing of Haemophilus influenzae.
    Diagn Microbiol Infect Dis. 1986 Feb;4(2):93-4 PMID: 3485504
  9. Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.
    Diagn Microbiol Infect Dis. 1986 Feb;4(2):95-107 PMID: 3485505
  10. In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.
    Antimicrob Agents Chemother. 1986 May;29(5):921-2 PMID: 3488019
  11. Josamycin: interpretation of inhibition zones with the Bauer-Kirby agar disk diffusion test as compared with erythromycin.
    Chemotherapy. 1986;32(4):336-43 PMID: 3731919
  12. Antibacterial activity of roxithromycin: a laboratory evaluation.
    J Antibiot (Tokyo). 1986 May;39(5):660-8 PMID: 3733515
  13. Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
    J Clin Microbiol. 1986 Aug;24(2):233-9 PMID: 3091634
  14. In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.
    Antimicrob Agents Chemother. 1986 Dec;30(6):865-73 PMID: 2949695
  15. Erythromycin concentrations in middle ear exudates.
    Pediatrics. 1971 Sep;48(3):417-22 PMID: 5094342
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1987-08-00
Pages
1243-50
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC174912
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]